CN112641919A - Acupoint application traditional Chinese medicine composition for yang-qi deficiency and vein stasis and preparation method thereof - Google Patents
Acupoint application traditional Chinese medicine composition for yang-qi deficiency and vein stasis and preparation method thereof Download PDFInfo
- Publication number
- CN112641919A CN112641919A CN202110177907.5A CN202110177907A CN112641919A CN 112641919 A CN112641919 A CN 112641919A CN 202110177907 A CN202110177907 A CN 202110177907A CN 112641919 A CN112641919 A CN 112641919A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- traditional chinese
- chinese medicine
- pepper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 230000007812 deficiency Effects 0.000 title claims abstract description 22
- 210000003462 vein Anatomy 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 23
- 239000006002 Pepper Substances 0.000 claims abstract description 23
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 23
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 23
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 23
- 241000218176 Corydalis Species 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 241000804384 Cynomorium songaricum Species 0.000 claims abstract description 12
- 241000758794 Asarum Species 0.000 claims abstract description 11
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 11
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 11
- 241000123589 Dipsacus Species 0.000 claims abstract description 10
- 241000701408 Euphorbia kansui Species 0.000 claims abstract description 10
- 241000488974 Loranthus Species 0.000 claims abstract description 8
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 5
- 230000003071 parasitic effect Effects 0.000 claims abstract description 5
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 4
- 244000301850 Cupressus sempervirens Species 0.000 claims abstract description 4
- 238000012545 processing Methods 0.000 claims abstract description 3
- 241000722363 Piper Species 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000572565 Alpinia oxyphylla Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 235000006463 Brassica alba Nutrition 0.000 claims description 7
- 244000140786 Brassica hirta Species 0.000 claims description 7
- 235000011371 Brassica hirta Nutrition 0.000 claims description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 7
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 7
- 244000273928 Zingiber officinale Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 244000237330 gutta percha tree Species 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 241000208688 Eucommia Species 0.000 claims description 5
- 206010041956 Stasis syndrome Diseases 0.000 claims description 5
- 229940107666 astragalus root Drugs 0.000 claims description 5
- 208000005634 blind loop syndrome Diseases 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 240000001638 Scurrula parasitica Species 0.000 claims description 3
- 241000220261 Sinapis Species 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 241001254604 Angelica pubescens Species 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 241000972672 Phellodendron Species 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 240000002045 Guettarda speciosa Species 0.000 claims 2
- 235000008216 herbs Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 208000002193 Pain Diseases 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 7
- 238000010792 warming Methods 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 244000203593 Piper nigrum Species 0.000 abstract 2
- 238000001467 acupuncture Methods 0.000 description 21
- 229940079593 drug Drugs 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 6
- 244000061520 Angelica archangelica Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 241000972673 Phellodendron amurense Species 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000034783 hypoesthesia Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides an acupoint application traditional Chinese medicine composition for yang qi deficiency and vein stasis and a preparation method thereof, wherein the traditional Chinese medicine composition is prepared by processing the following traditional Chinese medicine components in parts by weight: 12 parts of semen brassicae, 12 parts of rhizoma corydalis, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of fructus evodiae, 6 parts of pepper, 6 parts of clove, 12 parts of rhizoma cyperi, 6 parts of pepper, 12 parts of rhizoma zingiberis, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of cortex eucommiae, 15 parts of fructus alpiniae oxyphyllae, 10 parts of angelica sinensis, 30 parts of astragalus membranaceus, 15 parts of teasel roots, 12 parts of cynomorium songaricum, 12 parts of golden cypress, 15 parts of radix angelicae pubescentis, 12 parts of parasitic loranthus, 15 parts of glossy privet fruits and 12 parts of eclipta alba are added on the basis of tonifying qi and activating blood, warming meridians and dredging collaterals, promoting qi and relieving pain to prepare a traditional Chinese medicine application, and obtain a better curative effect through long.
Description
Technical Field
The invention belongs to the technical field of Chinese herbal medicines, and particularly relates to a traditional Chinese medicine composition for acupoint application for yang-qi deficiency and vein stasis, and a preparation method of the traditional Chinese medicine composition.
Background
The syndrome of stagnant vein due to insufficiency of yang-qi is a common clinical syndrome of traditional Chinese medicine, the etiology of which is that the yang-qi is insufficient and fails to circulate blood vessels, so that the muscles and tendons are nourished, or the patients are susceptible to cold, qi and blood stasis, and the chest is blocked, and the stagnation of vein is finally caused, and the clinical manifestations of the syndrome are listlessness, muscle atrophy, lack of qi and no speaking, preference for heat, fright, cold skin, cough, weakness, abdominal pain, diarrhea, little menstrual pain, weakness of hands and feet, discomfort of muscle during activities, dull tongue quality or petechia, ecchymosis and unsmooth pulse. The western medicine has limited understanding of the etiology and pathogenesis of the disease, and no specific and effective treatment method exists. The traditional Chinese medicine adopts a treatment method of tonifying qi and activating blood, warming and activating channels, and promoting qi circulation and relieving pain, and the oral traditional Chinese medicine decoction can achieve certain clinical effects. However, some patients cannot persist in taking the oral Chinese medicinal decoction for a long time, which increases the difficulty in treating the disease. The traditional Chinese medicine acupoint application can solve the problem instead of the traditional Chinese medicine oral administration, however, no traditional Chinese medicine acupoint application product related to the disease is available on the market at present.
Disclosure of Invention
Based on the problems in the prior art, the invention provides a traditional Chinese medicine composition for acupoint application for yang-qi deficiency and vein blood stasis, which is prepared by adding traditional Chinese medicines for invigorating yang and opening the channels and warming and tonifying spleen and kidney on the basis of benefiting qi and activating blood, warming and activating channels and collaterals, and promoting qi circulation and relieving pain under the guidance of Xuanfu theory, and achieves better curative effect through long-term clinical practice improvement.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a Chinese medicinal composition for acupoint application for treating yang qi deficiency and vein blood stasis comprises the following Chinese medicinal components: semen Sinapis Albae, rhizoma corydalis, radix kansui, herba asari, fructus evodiae, fructus Piperis, flos Caryophylli, rhizoma Cyperi, fructus Zanthoxyli, Zingiberis rhizoma, radix Aconiti lateralis Preparata, rhizoma Atractylodis, Eucommiae cortex, fructus Alpinae Oxyphyllae, radix Angelicae sinensis, radix astragali, radix Dipsaci, herba Cynomorii, cortex Phellodendri, radix Angelicae Pubescentis, herba Taxilli, fructus Ligustri Lucidi and Ecliptae herba.
According to the scheme, the traditional Chinese medicine composition for acupoint application for yang-qi deficiency and vein stasis comprises the following traditional Chinese medicine components in parts by weight:
10-14 parts of semen brassicae, 10-14 parts of rhizoma corydalis, 8-12 parts of euphorbia kansui, 1-5 parts of asarum, 4-8 parts of fructus evodiae, 4-8 parts of pepper, 4-8 parts of clove, 10-14 parts of rhizoma cyperi, 4-8 parts of pepper, 10-14 parts of rhizoma zingiberis, 13-17 parts of rhizoma typhonii, 10-14 parts of rhizoma atractylodis, 12-17 parts of eucommia ulmoides, 13-17 parts of fructus alpiniae oxyphyllae, 8-12 parts of angelica sinensis, 25-35 parts of astragalus membranaceus, 13-17 parts of radix dipsaci, 10-14 parts of cynomorium songaricum, 10-14 parts of cortex phellodendri, 13-17 parts of radix angelicae pubescentis, 10-14 parts of parasitic loranthus, 13-.
According to the scheme, the traditional Chinese medicine composition for acupoint application for yang-qi deficiency and vein stasis syndrome is prepared by processing the following traditional Chinese medicine components in parts by weight:
12 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia, 6 parts of pepper, 6 parts of clove, 12 parts of rhizoma cyperi, 6 parts of pepper, 12 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of eucommia bark, 15 parts of sharpleaf galangal fruit, 10 parts of angelica, 30 parts of astragalus root, 15 parts of teasel root, 12 parts of cynomorium songaricum, 12 parts of phellodendron, 15 parts of radix angelicae pubescentis, 12 parts of loranthus parasiticus, 15 parts of glossy privet fruit.
A preparation method of the traditional Chinese medicine composition comprises the following steps:
step S1, taking 15 parts of eucommia ulmoides, 12 parts of rhizoma cyperi, 30 parts of astragalus membranaceus, 15 parts of teasel roots, 12 parts of cynomorium songaricum, 12 parts of golden cypress, 12 parts of parasitic loranthus, 15 parts of glossy privet fruits and 12 parts of eclipta alba, adding water for decoction, filtering after decoction, taking filtrate, concentrating and drying to prepare dry paste;
step S2, grinding the dry paste prepared in step S1 into fine powder, and sieving to remove residues for later use;
step S3, respectively taking 12 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia rutaecarpa, 6 parts of pepper, 6 parts of clove, 6 parts of pepper, 12 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of sharpleaf galangal fruit, 10 parts of angelica and 15 parts of pubescent angelica root, crushing into fine powder, and sieving to remove residues for later use;
and step S4, uniformly mixing the fine powder prepared in the step S2 and the step S3 to obtain the finished product of the fine powder of the traditional Chinese medicine composition.
According to the scheme, in the step S1, water is added for decoction, and the water is added for decoction, wherein the water is 8 times of the total volume of the Chinese herbal medicine components.
According to the scheme, in the step S1, the water adding decoction is repeated twice, each time of the water adding decoction is firstly boiled by strong fire and then continuously decocted for one hour by low fire, and the liquid medicines obtained in the two times are combined and filtered.
The invention has the beneficial effects that: the rhizoma typhonii tablet, the eucommia ulmoides, the fructus alpiniae oxyphyllae, the cynomorium songaricum, the fructus evodiae, the asarum, the pepper, the clove, the rhizoma cyperi, the pepper, the rhizoma zingiberis and the rhizoma atractylodis in the traditional Chinese medicine composition applied to the acupuncture points are monarch drugs, have the effects of warming and tonifying spleen and kidney yang, dredging channels and collaterals and relieving pain, and aim at invigorating yang, promoting blood circulation and meridian circulation, and relieving yang-qi deficiency symptoms such as cold and shy body, cool skin, numbness of hands and feet; the Chinese angelica, the astragalus, the corydalis tuber and the teasel root are ministerial medicines, have the functions of tonifying qi and activating blood, promoting qi circulation and relieving pain, promote blood circulation and dredge channels, and assist monarch medicines to eliminate meridian stasis symptoms such as mental fatigue, limb fatigue, muscle soreness and the like, the traditional Chinese medicines are warm and easy to damage yin essence due to heat, so the glossy privet fruit, the eclipta alba, the kansui root and the phellodendron bark are used as adjuvants to nourish yin essence, clear heat and dissipate stagnation; the key pathogenesis of this disease is that the Xuan Fu stagnates and the vessels are blocked because Xuan Fu fails to warm and nourish yang qi due to yang qi deficiency and the vessels are blocked, so that the three-position wind-herbs of Du Huo, sang Ji Sheng and Bai Jie Zi are used to open Xuan Fu and dredge vessels. The medicines are combined to achieve the effects of warming and invigorating spleen and kidney, tonifying qi and activating blood, and dredging collaterals and relieving pain.
Detailed Description
The technical solution of the present invention will be described below with reference to specific examples.
The first embodiment is as follows: a Chinese medicinal composition for acupoint application for treating yang qi deficiency and blood stasis in channels and collaterals is provided.
A preparation method of a Chinese medicinal composition applied to acupuncture points for treating yang qi deficiency and vein blood stasis comprises the following steps:
step S1, weighing 15 parts of eucommia ulmoides, 12 parts of rhizoma cyperi, 30 parts of astragalus membranaceus, 15 parts of teasel roots, 12 parts of cynomorium songaricum, 12 parts of golden cypress, 12 parts of loranthus parasiticus, 15 parts of glossy privet fruits and 12 parts of eclipta alba according to the mass ratio, adding water which is 8 times of the total volume of the Chinese herbal medicine components for decocting, boiling with strong fire, continuously decocting for one hour with low fire, filtering and separating decoction dregs and liquid medicine after decocting, adding water into the decoction dregs, decocting once again, filtering to obtain liquid medicine, combining the liquid medicines obtained in the two steps, concentrating and drying to prepare dry paste;
step S2, grinding the dry paste prepared in step S1 into fine powder, and sieving to remove residues for later use;
step S3, weighing 12 parts of semen Sinapis Albae, 12 parts of rhizoma corydalis, 10 parts of radix kansui, 3 parts of herba asari, 6 parts of fructus evodiae, 6 parts of pepper, 6 parts of flos Caryophylli, 6 parts of pericarpium Zanthoxyli, 12 parts of rhizoma Zingiberis, 15 parts of rhizoma Typhonii, 12 parts of rhizoma Atractylodis, 15 parts of fructus Alpinae Oxyphyllae, 10 parts of radix Angelicae sinensis and 15 parts of radix Angelicae Pubescentis respectively according to the mass ratio, crushing into fine powder, and sieving to remove residues for later use;
and step S4, uniformly mixing the fine powder prepared in the step S2 and the step S3 to obtain the finished product of the fine powder of the traditional Chinese medicine composition.
Example two: effectiveness test of the Chinese medicinal composition applied to acupuncture points for treating yang qi deficiency and meridian stasis.
Case (sample) selection correlation criteria and selection grouping method.
1. Diagnostic criteria:
the diagnosis standard of the pattern of yang-qi deficiency and venation stasis is formulated according to the definition of the pattern of yang-qi deficiency and venation stasis in TCM syndrome:
(1) yang qi deficiency manifested by lassitude, fatigue, qi deficiency, disinclination to talk, aversion to heat, cold, loose stool, etc.;
(2) the manifestations of meridian stasis, such as heavy limbs, numbness of limbs, and muscular pain;
(3) a pale tongue with petechia and ecchymosis, and a thready and unsmooth or deep and thready pulse.
2. Inclusion (selection) criteria.
The patients who meet the diagnosis standard and are 18-80 years old and willing to receive acupuncture point application treatment.
3. Exclusion criteria.
Patients accompanying the following should be excluded from the subject: (1) allergic constitution and people allergic to various drugs; (2) the patient is not suitable for the acupoint application due to the self reasons (such as skin damage or inflammation at the acupoint part); (3) patients with serious diseases such as cardiovascular and cerebrovascular diseases, gastrointestinal tract, liver, kidney, hematopoietic system and endocrine system; (4) patients with diabetic peripheral neuropathy or limb venous thrombosis; (5) patients with mental illness or other conditions that lead to poor compliance; (6) the study panel did not scale to the number of patients undergoing the study.
4. And (5) removing, dropping and stopping test standards.
Rejection standard: patients who did not follow the study protocol during treatment.
Shedding standard: patients who did not complete the entire course of treatment and follow-up observations.
The abort criterion is: severe adverse reactions or severe complications occur in the implementation process of clinical trials.
5. A grouping situation.
All the cases are patients with yang qi deficiency and vein stasis syndrome, which are diagnosed in traditional Chinese medicine hospitals in 2016 (1) to 2020 (12), and the total number of the cases is 179. Subjects were randomized into treatment and control groups using randomization software. The patients in the treatment group are divided into a treatment group 1, a treatment group 2 and a treatment group 3 according to the sequence of the treatment group 1:1: 1.
Second, therapeutic (test) methods.
1. The acupoint application is carried out.
The acupuncture points are selected from Dazhui acupuncture point, Shenyu acupuncture point, Lung acupuncture point, Gaohuang acupuncture point, Tiantu acupuncture point, Shenque acupuncture point, Guanyuan acupuncture point and Zusanli acupuncture point, wherein calf nose acupuncture point and Xuehai acupuncture point are added for arthralgia patients, Sanyinjiao acupuncture point is added for dysmenorrhea patients, and Zhongwan acupuncture point is added for diarrhea and epigastric pain patients.
After selecting the acupuncture points, taking a certain amount of the fine powder of the traditional Chinese medicine composition and purified water with the temperature of 60-80 ℃, and mixing the following traditional Chinese medicine compositions in percentage by mass: purified water =2 g: 3ml of the mixture is fully and uniformly mixed to prepare medicinal mud; taking a proper amount of medicinal mud, rubbing into medicinal mud balls with the diameter of 1.0-1.5 cm, placing the medicinal mud balls in a plaster, and directly sticking the medicinal mud balls on the selected acupuncture points, wherein one plaster is stuck on each acupuncture point.
2. The Chinese medicinal composition components of different treatment groups and control groups are compared and tested.
The traditional Chinese medicine composition of the treatment group 1 comprises 12 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia rutaecarpa, 6 parts of pepper, 6 parts of clove, 12 parts of rhizoma cyperi, 6 parts of pepper, 12 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of eucommia bark, 15 parts of sharpleaf galangal fruit, 10 parts of angelica, 30 parts of astragalus root, 15 parts of teasel root, 12 parts of cynomorium songaricum, 12 parts of phellodendron bark, 15 parts of radix angelicae pubescentis, 12 parts of loranthus. The acupoint application is carried out for 4-6 h/time, every other day is 1 time, 5 times are 1 treatment course, and 2 treatment courses are total.
The traditional Chinese medicine composition of the treatment group 2 comprises 10 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia rutaecarpa, 4 parts of pepper, 6 parts of clove, 12 parts of rhizoma cyperi, 4 parts of pepper, 10 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 12 parts of eucommia bark, 15 parts of sharpleaf galangal fruit, 10 parts of angelica, 30 parts of astragalus root, 15 parts of teasel root, 10 parts of cynomorium songaricum, 12 parts of phellodendron bark, 15 parts of radix angelicae pubescentis, 12 parts of loranthus. The acupoint application is carried out for 4-6 h/time, every other day is 1 time, 5 times are 1 treatment course, and 2 treatment courses are total.
The traditional Chinese medicine composition of the treatment group 3 comprises 10 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia rutaecarpa, 6 parts of pepper, 6 parts of clove, 12 parts of rhizoma cyperi, 6 parts of pepper, 12 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of eucommia bark, 15 parts of sharpleaf galangal fruit, 10 parts of angelica, 30 parts of astragalus root, 15 parts of teasel root, 12 parts of cynomorium songaricum, 12 parts of phellodendron bark, 12 parts of radix angelicae pubescentis, 10 parts of loranthus. The acupoint application is carried out for 4-6 h/time, every other day is 1 time, 5 times are 1 treatment course, and 2 treatment courses are total.
The composition in the control group comprises a mixture of food pigment, dextrin and starch, and is applied to acupuncture points for 4-6 h/time, 1 time every other day, and 5 times of the composition are 1 treatment course for 2 treatment courses.
3. The evaluation standard of the curative effect of the syndrome of yang-qi deficiency and vein blood stasis.
The traditional Chinese medicine is formulated according to the traditional Chinese medicine syndrome curative effect standard in the clinical research guiding principle of new traditional Chinese medicines issued by the ministry of health of China.
(1) And (3) healing: the original symptoms completely disappear, and no relapse occurs within 6 months after the treatment is stopped;
(2) the effect is shown: the original symptoms are obviously improved, and only slight numbness, pain or discomfort is left;
(3) the method has the following advantages: the original symptoms are slightly relieved;
(4) and (4) invalidation: the original symptoms are not obviously improved or are aggravated.
And thirdly, testing results.
1. Clinical curative effect
The total effective rate of the treatment group is 84.44% (76 cases/90 cases), the total effective rate of the control group is 5.62% (5 cases/90 cases), the comparison difference of the two groups has statistical significance (P is less than 0.01), namely, the curative effect of the treatment group is obviously better than that of the control group, and detailed results are shown in table 1.
TABLE 1 comparative therapeutic effect of each group (example)
| Group of | Number of examples | Recovery method | Show effect | Is effective | Invalidation | High efficiency |
| Treatment group 1 | 30 | 4 | 16 | 7 | 3 | 90.00% |
| Treatment group 2 | 30 | 2 | 14 | 9 | 5 | 83.33% |
| Treatment group 3 | 30 | 6 | 10 | 8 | 6 | 80.00% |
| Control group 1 | 89 | 0 | 0 | 5 | 84 | 5.62% |
2. Adverse reaction
No obvious adverse reaction is seen in the control group; in the treatment group, only 2 patients showed local skin redness after 6h of application, and all of the redness resolved within 24 hours after drug withdrawal without other adverse effects.
The above embodiments are only used for illustrating but not limiting the technical solutions of the present invention, and although the above embodiments describe the present invention in detail, those skilled in the art should understand that: modifications and equivalents may be made thereto without departing from the spirit and scope of the invention and any modifications and equivalents may fall within the scope of the claims.
Claims (6)
1. A traditional Chinese medicine composition for acupoint application for yang-qi deficiency and vein stasis syndrome is characterized by comprising the following traditional Chinese medicine components: semen Sinapis Albae, rhizoma corydalis, radix kansui, herba asari, fructus evodiae, fructus Piperis, flos Caryophylli, rhizoma Cyperi, fructus Zanthoxyli, Zingiberis rhizoma, radix Aconiti lateralis Preparata, rhizoma Atractylodis, Eucommiae cortex, fructus Alpinae Oxyphyllae, radix Angelicae sinensis, radix astragali, radix Dipsaci, herba Cynomorii, cortex Phellodendri, radix Angelicae Pubescentis, herba Taxilli, fructus Ligustri Lucidi and Ecliptae herba.
2. The traditional Chinese medicine composition for acupoint application for yang qi deficiency and vein stasis syndrome according to claim 1, which comprises the following traditional Chinese medicine components in parts by weight:
10-14 parts of semen brassicae, 10-14 parts of rhizoma corydalis, 8-12 parts of euphorbia kansui, 1-5 parts of asarum, 4-8 parts of fructus evodiae, 4-8 parts of pepper, 4-8 parts of clove, 10-14 parts of rhizoma cyperi, 4-8 parts of pepper, 10-14 parts of rhizoma zingiberis, 13-17 parts of rhizoma typhonii, 10-14 parts of rhizoma atractylodis, 12-17 parts of eucommia ulmoides, 13-17 parts of fructus alpiniae oxyphyllae, 8-12 parts of angelica sinensis, 25-35 parts of astragalus membranaceus, 13-17 parts of radix dipsaci, 10-14 parts of cynomorium songaricum, 10-14 parts of cortex phellodendri, 13-17 parts of radix angelicae pubescentis, 10-14 parts of parasitic loranthus, 13-.
3. The traditional Chinese medicine composition for acupoint application for yang qi deficiency and vein stasis syndrome according to claim 2, which is prepared by processing the following traditional Chinese medicine components in parts by weight into fine powder and mixing the fine powder:
12 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia, 6 parts of pepper, 6 parts of clove, 12 parts of rhizoma cyperi, 6 parts of pepper, 12 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of eucommia bark, 15 parts of sharpleaf galangal fruit, 10 parts of angelica, 30 parts of astragalus root, 15 parts of teasel root, 12 parts of cynomorium songaricum, 12 parts of phellodendron, 15 parts of radix angelicae pubescentis, 12 parts of loranthus parasiticus, 15 parts of glossy privet fruit.
4. A method for preparing a Chinese medicinal composition as claimed in any one of claims 1 to 3, comprising the steps of:
step S1, taking 15 parts of eucommia ulmoides, 12 parts of rhizoma cyperi, 30 parts of astragalus membranaceus, 15 parts of teasel roots, 12 parts of cynomorium songaricum, 12 parts of golden cypress, 12 parts of parasitic loranthus, 15 parts of glossy privet fruits and 12 parts of eclipta alba, adding water for decoction, filtering after decoction, taking filtrate, concentrating and drying to prepare dry paste;
step S2, grinding the dry paste prepared in step S1 into fine powder, and sieving to remove residues for later use;
step S3, respectively taking 12 parts of white mustard seed, 12 parts of corydalis tuber, 10 parts of euphorbia kansui, 3 parts of asarum, 6 parts of evodia rutaecarpa, 6 parts of pepper, 6 parts of clove, 6 parts of pepper, 12 parts of dried ginger, 15 parts of rhizoma typhonii, 12 parts of rhizoma atractylodis, 15 parts of sharpleaf galangal fruit, 10 parts of angelica and 15 parts of pubescent angelica root, crushing into fine powder, and sieving to remove residues for later use;
and step S4, uniformly mixing the fine powder prepared in the step S2 and the step S3 to obtain the finished product of the fine powder of the traditional Chinese medicine composition.
5. The method of claim 4, wherein in step S1, the decoction is carried out with water in an amount 8 times the total volume of the herbs.
6. The method of claim 4, wherein the water decoction is repeated twice in step S1, each time the water decoction is boiled with strong fire and then decocted with low fire for one hour, and the two decoctions are combined and filtered.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110177907.5A CN112641919A (en) | 2021-02-09 | 2021-02-09 | Acupoint application traditional Chinese medicine composition for yang-qi deficiency and vein stasis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110177907.5A CN112641919A (en) | 2021-02-09 | 2021-02-09 | Acupoint application traditional Chinese medicine composition for yang-qi deficiency and vein stasis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112641919A true CN112641919A (en) | 2021-04-13 |
Family
ID=75370988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110177907.5A Pending CN112641919A (en) | 2021-02-09 | 2021-02-09 | Acupoint application traditional Chinese medicine composition for yang-qi deficiency and vein stasis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112641919A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013605A (en) * | 2014-06-17 | 2014-09-03 | 上海中医药大学附属曙光医院 | Traditional Chinese medicinal patch as well as preparation method and use thereof |
| CN111701005A (en) * | 2020-07-15 | 2020-09-25 | 卢春兰 | A Chinese medicinal mud moxibustion for treating lumbago |
-
2021
- 2021-02-09 CN CN202110177907.5A patent/CN112641919A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013605A (en) * | 2014-06-17 | 2014-09-03 | 上海中医药大学附属曙光医院 | Traditional Chinese medicinal patch as well as preparation method and use thereof |
| CN111701005A (en) * | 2020-07-15 | 2020-09-25 | 卢春兰 | A Chinese medicinal mud moxibustion for treating lumbago |
Non-Patent Citations (1)
| Title |
|---|
| 谢文光等: "《中医配方学》", 30 June 2000, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN100998838A (en) | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof | |
| CN109010468A (en) | Antitumor Chinese and its preparation method and application based on ancient prescription Tuoli Xiaodu | |
| CN106729580A (en) | Treat the Chinese medicine of apoplexy at acute stage | |
| CN102631538B (en) | Traditional Chinese medicine for treating heart disease | |
| CN102784332A (en) | Medicine for treating angiitis | |
| CN103751477A (en) | Traditional Chinese medicine composition for treating slurred speech of phlegm-damp blocking cerebral infarction patient | |
| CN109966444A (en) | A kind of herbal mediciment and device for treating cerebral infarction | |
| CN112641919A (en) | Acupoint application traditional Chinese medicine composition for yang-qi deficiency and vein stasis and preparation method thereof | |
| CN101983672A (en) | Medicament for treating cramp | |
| CN105456379A (en) | Decoction for treating blood deficiency intestinal dryness constipation and preparation method thereof | |
| CN104666805A (en) | Chinese patent medicine particles for treating diabetes | |
| CN105169294A (en) | Traditional Chinese medicine ointment for treating scapulohumeral periarthritis | |
| CN111973720A (en) | A Chinese medicinal composition for treating mastitis and hyperplasia of mammary glands, and its preparation method | |
| CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN105079438B (en) | A kind of pharmaceutical preparation for treating vital myocarditis | |
| CN110787237B (en) | Traditional Chinese medicine composition for effectively treating gastrocnemius spasm and preparation method and application thereof | |
| CN103550736B (en) | Traditional Chinese medicine for treating blood stasis and channel blockage symptom type amenorrhea | |
| CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN105055753A (en) | Hemorrhoid ointment and preparation process thereof | |
| CN101219202A (en) | Soup for strengthening tendon and waist | |
| CN105395894A (en) | Traditional Chinese medicine fumigant lotion for treating diabetic peripheral neuropathy and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |